Category: Financial News
Financial related news
Sunnyvale, Calif.-based Accuray Inc. predicts flat sales and a break-even year as the company looks to make up a $24 million hole in its revenues.
Accuray Inc. (NSDQ:ARAY) is starting 2011 with a sizable hole in its top line that will hamper sales growth and profits over the next year, company officials said in a conference call with analysts.
ClearCount Medical Solutions raises $5 million in a Series B funding round.
ClearCount Medical Solutions Inc. closed its Series B funding round with a hoped-for $5 million.
ClearCount is developing the SmartSponge and SmartWand systems, which use radio-frequency identification technology and chips embedded in sponges to allow surgeons and nurses to detect and count sponges during surgeries.
Medical device companies are scaling back their hopes for initial public offerings, even as IPOs surge for other industries.
In a recent story, "The Return of the IPO," Fortune magazine proclaimed initial public offerings have roared back to life, noting successful IPOs by Tesla Motors (NSDQ:TSLA) and RealD (NYSE:RLD), a maker of 3D film technology.
EndoGastric Solutions Inc., which makes tissue-stapling equipment for the stomach and esophagus, drums up a $30 million Series F round, while Aptus EndoSystems Inc. reels in a $15 million Series AA round.
California-based EndoGastric Solutions Inc. and Aptus EndoSystems Inc. brought in $30 million and $15 million, respectively, in separate funding rounds.
Menlo Park, Calif.-based Canaan Partners and New York-based Radius Ventures led EndoGastric's $30 million Series F round, which was designed to support the company through profitability, according to a press release.
WaveMark Inc. completes a $3.9 million equity offering.
Healthcare radio frequency identification technology firm WaveMark Inc. brought in $3.9 million in an equity offering, according to a Securities & Exchange Commission filing.
The Littleton, Mass.-based firm raised the cash from 20 different investors, according to the Aug. 25 filing.
WaveMark makes RFID products for the healthcare industry that enable hospitals and medical device suppliers to track their inventories.
Fresh off the collapse of a merger with WuXi PharmaTech, Charles River Laboratories International Inc. expedites a $300 million share repurchasing plan and takes out a $750 million credit line.
Charles River Laboratories International Inc. (NYSE:CRL), fresh from the collapse of a proposed, $1.6 billion merger with WuXi PharmaTech (Cayman) Inc. (NYSE:WX), plans to accelerate a $300 million stock buyback and took out a $750 million credit line.
The Wilmington, Mass.-based contract research organization said the repurchasing plan will see it buy back 6 million shares initially, with the final number to be determined based on a discounted price based on its daily volume-weighted average price during a a six-month-or-less period as determined by Morgan Stanley & Co. Inc., which is brokering the buyback.
ThermoGenesis Corp. consolidates its stock to stave off a possible de-listing from the NASDAQ exchange.
ThermoGenesis Corp. (NSDQ:KOOL) will reverse-split its stock tomorrow.
The board of the Rancho Cordova, Calif.-based company approved the move in an attempt to boost its share price. ThermoGenesis faces being de-listed from the NASDAQ stock exchange unless it meets the market's minimum $1-per-share requirement.
